Principia Biopharma Inc. Patent Application Trends in 2024
Principia Biopharma Inc. Patent Filing Activity
Principia Biopharma Inc. patent applications in 2024
Error creating thumbnail: File missing
Top 10 Technology Areas
- A61K31/519 (No explanation available)
- Count: 4 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- C07D487/04 (No explanation available)
- C07B2200/13 (No explanation available)
- Count: 2 patents
- Example: [[20240182484. Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- A61K31/5377 (No explanation available)
- A61K45/06 (No explanation available)
- C07D519/00 (No explanation available)
- C07D487/14 (No explanation available)
- Count: 1 patents
- Example: [[20240182484. Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- C07F5/025 (No explanation available)
- Count: 1 patents
- Example: 20240199655. Immunoproteasome Inhibitors simplified abstract (Principia Biopharma Inc.)
- A61K9/2018 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- A61K9/2846 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
Emerging Technology Areas
- C07D471/04 (No explanation available)
- C07D405/12 (No explanation available)
- C07D403/12 (No explanation available)
- C07D401/14 (No explanation available)
- A61K31/506 (No explanation available)
- A61K31/495 (No explanation available)
- A61K9/0053 (No explanation available)
- A61P7/04 (No explanation available)
- A61P7/02 (No explanation available)
- A61K9/5073 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
Top Inventors
- Pasit Phiasivongsa of Hillsborough CA (US) (2 patents)
- Kolbot By of San Ramon CA (US) (2 patents)
- Mohammad R. Masjedizadeh of San Jose CA (US) (2 patents)
- Erik Verner of Belmont CA (US) (2 patents)
- Jean Baum of San Bruno CA (US) (1 patent)
- Yan Lou of Pleasanton CA (US) (1 patent)
- Timothy Duncan Owens of Redwood City CA (US) (1 patent)
- Kenneth Albert Brameld of Hillsborough CA (US) (1 patent)
- David Michael Goldstein of Redwood City CA (US) (1 patent)
- Abu J. Ferdous of Belmont CA (US) (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- Principia Biopharma Inc.
- Companies
- CPC C07D487/14
- CPC C07B2200/13
- CPC C07F5/025
- CPC A61K31/519
- CPC A61K9/2018
- CPC A61K9/2846
- CPC A61K9/2866
- CPC A61K9/2886
- CPC A61K9/5026
- CPC A61K9/5047
- CPC A61K9/5073
- CPC A61P7/02
- CPC A61P7/04
- CPC C07D487/04
- CPC A61K9/0053
- CPC A61K31/495
- CPC A61K31/506
- CPC A61K31/5377
- CPC A61K45/06
- CPC C07D401/14
- CPC C07D403/12
- CPC C07D405/12
- CPC C07D519/00
- CPC C07D471/04
- Patent Trends by Company in 2024